Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Grass MATA MPL in Grass Pollen Allergy
NCT00414141Phase 3Completed
- Sponsor
- Allergy Therapeutics PLC
- Start
- Nov 2006
- Primary completion
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 3 trial of Grass MATA MPL in seasonal allergic rhinitis (SAR), allergic conjunctivitis (AC), sponsored by Allergy Therapeutics PLC. Started Nov 2006; status: completed.
02
Drugs
Grass MATA MPL
03
Conditions
seasonal allergic rhinitis (SAR)allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT00414141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414141.